CLINICAL ROLE -
A Link Between Marriage and Cancer Survival
New research shows that being married is associated with higher survival rates in cancer patients.
Read More
Experimental Drug Boosts Outcomes in Relapsing Multiple Sclerosis
Zinbryta found to reduce cells that contribute to neurological injury caused by multiple sclerosis.
Generic Hepatitis C Treatment Shows Equivalent Efficacy to Branded Treatments
Treating hepatitis C could potentially be less expensive with generic treatments.
Generic Hepatitis C Treatments May Lower Costs with Equal Efficacy
Trending News Today: Generic Competition Lowers Cancer Drug Revenue
Top news of the day from across the healthcare landscape.
Trending News Today: Battle Continues Between Express Scripts and Anthem Inc
Once Daily Epilepsy Drug Deemed Non-Inferior to Twice-Daily Treatment
Eslicarbazepine acetate may help patients adhere to their medication schedule.
Harvoni Shows Promise Treating Hepatitis C in Adolescents
Overall positive results shown in studies with Harvoni and sofosbuvir/velpatasvir.
Positive Results Seen in Ibrance Breast Cancer Trial
Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.
New Cholesterol-Fighting Compound Could Potentially Improve Prostate Cancer Treatment
RO 48-8971 may inhibit the growth of and kill prostate cancer cells.
Global Spending on Health Expected to Increase Significantly by 2040
Global spending on healthcare expected to exceed $18 trillion over next 25 years.
Differing Results: HIV and HCV Coinfection and How It Affects Direct-Acting Antivirals
Two studies produce two very different results treating a hepatitis C-HIV coinfection.
Treatment with Tecfidera Improves Long-term Outcomes in Multiple Sclerosis Patients
A recent Tecfidera study finds find no rate of relapse of progression in MS patients.
Immunosuppressive Therapy May Be a Better Treatment for Ocular Graft-Versus-Host-Disease
Current steroid treatment may leave patients with cataracts.
Experimental Drug Guadecitabine Proven Safe for Colorectal Cancer Treatment
Guadecitabine and chemotherapy can potentially overcome treatment resistance.
Trending News Today: UnitedHealthcare Threatens to Leave Health Insurance Marketplace
Prescription Drug Spending to Rise Significantly Through 2020
Pharmacy benefit managers found to help limit spending growth on branded drugs last year.
Improved Education Needed for FDA Approval Terminology
FDA approved and “breakthrough therapy” are two commonly used phrases in regards to pharmaceuticals, but physicians may not fully understand the meaning of these terms.
Discovering Alternate Routes Cancer Cells Travel Can Lead to Better Treatments
Drug resistance is better understood through mapping out alternate paths cancer cells take in order to avoid targeted treatment.
Trending News Today: Pharmaceutical Company Pays Up to Resolve Fraud Case
The Most Complete Map for Scleroderma Has Been Created
Genetic map may lead to new targeted treatments for scleroderma.
Cost-Sharing On the Rise Among Workers with Employer-Sponsored Health Insurance
The average deductible jumped from $303 in 2006 to $1077 in 2014.
New Treatment Target Found for Cancer, Chronic Pain
Discovery may lead to pharmaceutical compounds that target protein structure.
Crizotinib Resistance Can Potentially Be Reversed
A new study shows that genes can become sensitive to crizotinib after the introduction of ponatinib.
Trending News Today: Lawsuit Filed Over Hepatitis C Drug Access
Alzheimer's Disease Inhibiting Insulin Signaling in the Brain May Cause Diabetes
Improving insulin signaling in the brain may reduce the likelihood patients with Alzheimer's disease develop diabetes.
Macro-Trends That Effect Healthcare Benefit Strategies
Eight macro-trends for employers to consider when creating a healthcare plan